has function has role immunizes against disease immunizes recipient colorectal cancer Homo sapiens therapeutic vaccine function peptide vaccine vaccine in clinical trial role peptide vaccine role colorectal cancer vaccine therapeutic cancer vaccine HER-2-neu, CEA peptides, GM-CSF, montanide ISA-51 vaccine Gene name: carcinoembryonic antigen NCI: https://ncithesaurus.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=ncit&code=C48392 Hayleigh Kahn 1048 cancer vaccine 2064 A cancer vaccine comprised of HER-2-neu and carcinoembryonic antigen synthetic (CEA) peptides, combined with the adjuvants granulocyte-macrophage colony stimulating factor (GM-CSF), and Montanide ISA-51 with potential antineoplastic activity. The vaccine may stimulate a cytotoxic T-cell response against HER-2-neu- and CEA-expressing tumor cells. Vaccines made from peptides may make the body build an immune response to kill tumor cells. This vaccine is compromised of HER-2-neu and carcinoembryonic antigen synthetic peptides, sargramostim (GM-CSF), and Montanide ISA-51, and aims to cause an immune response in patients with stage IIB, III, or IV colorectal cancer. Jie Zheng NCT: https://clinicaltrials.gov/study/NCT00091286 Gene name: HER-2-neu 6294 VIOLIN: https://violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=6294